Supriya Lifescience Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2025. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience held its 17th AGM on September 24, 2025 via video conferencing, with all five resolutions passed with the required majority. Shareholders approved the audited financial statements for FY 2024-25 and declared a final dividend of Re. 1.00 (50%) per equity share on shares of face value Rs. 2 each. Mr. Balasaheb Sawant, who retires by rotation, was re-appointed as a director with 98.37% votes in favour. The remuneration of Cost Auditors for FY 2025-26 was ratified, and M/s DSM & Associates was appointed as Secretarial Auditors for a five-year term (FY 2025-26 to FY 2029-30). Voting was carried out through remote e-voting via NSDL, with 73.29% of total share capital participating across all resolutions.
Eligible shareholders will receive a final dividend of Re. 1 per share for FY 2024-25. The smooth passage of all resolutions, with near-unanimous support, signals strong shareholder confidence and no governance concerns.